No Stock Yet
Changchun High & New Technology Selling Real Estate Unit to Largest Shareholder
12:47 AM EDT, 03/22/2023 (MT Newswires) -- Changchun High & New Technology Industries Group (SHE:000661) is selling its real estate unit, Changchun High-Tech Real Estate Development, to the company's
Nanshui Water | Nanshui buys 584 million yuan in Maotai; Beishui grabbed shares of Science and Technology Network and increased its holdings in Tencent and Meituan
The total net purchases of Southbound Capital exceeded HK$1,013 million throughout the day.
Changchun Hi-Tech (000661): Real estate divestment is implemented, and I'm optimistic that new cases will return to high growth in 23
Incident: The company announced that it intends to transfer 100% of its shares in Gaoxin Real Estate to the controlling shareholder Chaoda Group. The consideration for this transaction will be raised by Chaoda Group through the issuance of exchangeable corporate bonds. Divestment of the real estate business is expected to improve the company's cash flow and benefit the company's long-term development. The high-tech real estate business has a great impact on the company's overall cash flow. The transfer is carried out through an agreement transfer. The company will further focus on the core biomedical business, which is conducive to enhancing the company's balance and liability structure, enhancing the company's sustainable development capacity, enhancing the company's profitability and core competitiveness, and benefiting the company's long-term development. Consider 2
Beishui grabs science and technology network stocks! Tencent added more than HK$1.2 billion to buy Meituan over HK$200 million; Nanshui added Kweichow Maotai to nearly 600 million yuan
Southbound Capital received a net purchase of HK$1,013 million, Pharmaceutical Biotech received a net purchase of HK$415 million. Hang Seng Chinese companies had the highest net sales volume of HK$1,024 million; Northbound Capital made a net purchase of $4.295 billion today, while IFF and Changchun Hi-Tech received net purchases of $306 million and $228 million respectively.
Northbound Capital made a net purchase of 4,295 billion yuan today. Kweichow Moutai, IFF, and Changchun Hi-Tech received net purchases of 584 million yuan, 306 million yuan, and 228 million yuan respectively. Shanxi Fenjiu had the highest net sales volume
A-share midday announcement
Gelonghui March 21 丨 ① Changchun Hi-Tech: Chaoda Group, the largest shareholder of the company, increased its shares by 179,500 shares through centralized bidding on March 21. ② Linote Glass: The construction and installation of the first production line for the company's initial public offering project “High Borosilicate Glass Production Project for LED Optical Lenses” has been completed. On March 21, 2023, the first kiln producing high borosilicate LED optical lens glass was successfully ignited. ③ Kaichun Co., Ltd.: The company plans to purchase real estate located in Lane 2339 of Chenxing Road in Shanghai's Lingang Pujiang International Science and Technology City Development Co., Ltd.
Changchun Hi-Tech (000661.SZ): Chaoda Group, the largest shareholder, increased its holdings by 179,500 shares
Gelonghui, March 21丨Changchun Hi-Tech (000661.SZ) announced that the company received a notice from Chaoda Group, the largest shareholder. Chaoda Group increased its shares by 179,500 shares through centralized bidding through the Shenzhen Stock Exchange trading system on March 21, 2023, accounting for 0.04% of the company's total share capital. After this increase in holdings, Chaoda Group held 76.254.54 million shares of the company, accounting for 18.84% of the company's total share capital.
Changchun Hi-Tech's plan to divest the real estate business has sparked speculation in the bureau's adjustments. Company: No plans to divest proprietary Chinese medicines
Gelonhui, March 21丨According to every report, the Changchun Hi-Tech Securities Department said that the company divested the real estate business due to comprehensive considerations of the subsidiary's actual operating situation and shareholders' voices, and there are no plans to continue divesting other businesses in the future. Furthermore, from the national policy level, the country strongly supports the traditional Chinese medicine industry. The company will continue to focus on the core biomedical business segment in the future.
Changes in A-shares | Changchun Hi-Tech plans to sell 4% of Gaoxin Real Estate's shares to focus on biomedical business
Gelonghui, March 21, 丨 Changchun Hi-Tech (000661.SZ) opened 4.35% higher to 164.5 yuan, with a total market value of 66.6 billion yuan. Changchun Hi-Tech announced on March 20 that according to the company's future development strategy, in order to focus on the biomedical core business sector, optimize the industrial layout and resource allocation, highlight the core advantages of the main business, improve the balance and liability structure, and raise the company's cash flow level, the company plans to sell 100% of its wholly-owned subsidiary Changchun Gaoxin Real Estate Development Co., Ltd. (“Chaoda Group” for short) to the controlling shareholder of the company, Changchun Gaoxin Real Estate Development Co., Ltd. (“Gaoxin Real Estate”)
Changchun Hi-Tech (000661.SZ): Focusing on the core biomedical business sector, plans to transfer 100% of Gaoxin Real Estate's shares to the controlling shareholder
Gelonhui, March 20, 丨 Changchun Hi-Tech (000661.SZ) announced that according to the company's future development strategy, in order to focus on the biomedical core business segment, optimize the industrial layout and resource allocation, highlight the core advantages of the main business, improve the balance and liability structure, and increase the company's cash flow level, the company plans to transfer 100% of its shares in Changchun Gaoxin Real Estate Development Co., Ltd. (“Gaoxin Real Estate”) to Chaoda Group, the controlling shareholder of the company. The company held the 22nd meeting of the 10th board of directors on March 20, 2023 to deliberate and pass the “Proposal on Signing a Framework Agreement on Equity Transfer and Related Transactions
No Stock Yet